HCWB
HCW Biologics Inc.NASDAQHealthcare$0.27-10.70%ClosedMarket Cap: $558,798
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.22
P/S
11.05
EV/EBITDA
-0.48
DCF Value
$-8.37
FCF Yield
-2233.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
-300.7%
Operating Margin
-24299.0%
Net Margin
-41117.2%
ROE
1121.0%
ROA
-90.9%
ROIC
-128.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $27.0K | 20.0% | $-4.5M | $-13.6M | $-1.77 | — |
| FY 2025 | $54.2K | 20.0% | $-13.2M | $-22.3M | $-10.63 | — |
| Q3 2025 | $15.6K | -1094.3% | $-3.3M | $-4.6M | $-2.02 | — |
| Q2 2025 | $6.5K | 20.0% | $-3.5M | $-1.9M | $-6.79 | — |
| Q1 2025 | $5.1K | 20.0% | $-2.0M | $-2.2M | $-0.05 | — |
| Q4 2024 | $394.8K | 20.0% | $-3.2M | $-3.4M | $-0.08 | — |
| FY 2024 | $2.6M | 37.4% | $-29.5M | $-30.0M | $-0.77 | — |
| Q3 2024 | $426.4K | 20.0% | $-3.7M | $-3.9M | $-0.10 | — |
| Q2 2024 | $618.9K | 29.2% | $-15.1M | $-15.3M | $-0.40 | — |
| Q1 2024 | $1.1M | 54.6% | $-7.5M | $-7.5M | $-0.20 | — |
| Q4 2023 | $1.3M | -377.4% | $-10.8M | $-10.7M | $-0.30 | — |
| FY 2023 | $2.8M | 19.7% | $-25.7M | $-25.0M | $-0.70 | — |